Impact of exogenous lactate on survival and radioresponse of carcinoma cells in vitro

International Journal of Radiation Biology

Volumn 85, Issue 11, 2009, Pages 989-1001

  Grotius, Janine ^a   Dittfeld, Claudia ^a   Huether, Melanie ^a   Mueller Klieser, Wolfgang ^b   Baumann, Michael ^a   Kunz Schughart, Leoni A ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Acidosis; Cell survival; Irradiation; Lactate; MCT1; Radioresponse; Tumour pathophysiology

Indexed keywords

CD147 ANTIGEN; LACTIC ACID; MONOCARBOXYLATE TRANSPORTER 1;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CARCINOMA CELL; CELL STRAIN HCT116; CELL STRAIN HNSCC; CELL STRAIN HT29; CELL SURVIVAL; CLONOGENESIS; COLONY FORMATION; CONTROLLED STUDY; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; LACTIC ACIDOSIS; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION EXPOSURE; RADIATION RESPONSE; RADIOSENSITIVITY;

ACIDOSIS; ANTIGENS, CD147; CARCINOMA; CELL LINE, TUMOR; CELL SURVIVAL; GLUCOSE; HCT116 CELLS; HT29 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; LACTIC ACID; MONOCARBOXYLIC ACID TRANSPORTERS; RADIATION TOLERANCE; SYMPORTERS; TUMOR STEM CELL ASSAY;

EID: 70449507024     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.3109/09553000903242156     Document Type: Article

References (52)

1. Baumann F, Leukel P, Doerfelt A, Beier CP, Dettmer K, Oefner PJ, Kastenberger M, Kreutz M, Nickl-Jockschat T, Bogdahn U, Bosserhoff AK, Hau, P. 2009. Lactate promotes glioma migration by TGF-beta2 dependent regulation of matrix metalloproteinase-2. Neuro-Oncology 11:368-380.
2. Bensaad K, Vousden KH. 2007. p53: New roles in metabolism. Trends in Cell Biology 17:286-291.
3. Bertout JA, Patel SA, SimonMC. 2008. The impact ofO2 availability on human cancer. Nature Reviews in Cancer 8:967-975.
4. Brizel DM, Schroeder T, Scher RL, Walenta S, Clough RW, Dewhirst MW, Mueller-Klieser W. 2001. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. International Journal of Radiation Oncology, Biology, Physics 51:349-353.
5. Cheeti S, Warrier BK, Lee CH. 2006. The role of monocarboxylate transporters in uptake of lactic acid in HeLa cells. International Journal of Pharmaceutics 325:48-54.
6. Chesney J. 2006. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis. Current Opinion in Clinical Nutrition and Metabolic Care 9:535-539.
7. Deberardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, Thompson CB. 2007. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proceedings of the National Academy of Sciences of the United States of America 104:19345-19350.
8. Dimmer KS, Friedrich B, Lang F, Deitmer JW, Broer S. 2000. The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochemical Journal 350Pt 1:219-227.
9. Eicheler W, Zips D, Dorfler A, Grenman R, Baumann M. 2002. Splicing mutations in TP53 in human squamous cell carcinoma lines influence immunohistochemical detection. Journal of Histochemistry and Cytochemistry 50:197-204.
10. Fischer K, Hoffmann P, Voelkl S, Meidenbauer N, Ammer J, Edinger M, Gottfried E, Schwarz S, Rothe G, Hoves S, Renner K, Timischl B, Mackensen A, Kunz-Schughart L, Andreesen R, Krause SW, Kreutz M. 2007. Inhibitory effect of tumor cellderived lactic acid on human T cells. Blood 109:3812-3819.
11. Fukumura D, Jain RK. 2007. Tumor microenvironment abnormalities: Causes, consequences, and strategies to normalize. Journal of Cellular Biochemistry 101:937-949.
12. Fukumura D, Jain RK. 2008. Imaging angiogenesis and the microenvironment. Acta Pathologica, Microbiologica, et Immunologica Scandinavica 116:695-715.
13. Ganapathy V, Thangaraju M, Prasad PD. 2009. Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond. Pharmacology & Therapeutics 121:29-40.
14. Gatenby RA, Gillies RJ. 2004. Why do cancers have high aerobic glycolysis? Nature Reviews in Cancer 4:891-899.
15. Gayet J, Zhou XP, Duval A, Rolland S, Hoang JM, Cottu P, Hamelin R. 2001. Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. Oncogene 20:5025-5032.
16. Gottfried E, Kunz-Schughart LA, Andreesen R, Kreutz M. 2006. Brave little world: Spheroids as an in vitro model to study tumor-immune-cell interactions. Cell Cycle 5:691-695.
17. Gottfried E, Kunz-Schughart LA, Ebner S, Mueller-Klieser W, Hoves S, Andreesen R, Mackensen A, Kreutz M. 2006. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood 107:2013-2021.
18. Halestrap AP, Meredith D. 2004. The SLC16 gene family - from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Archiv. European Journal of Physiology 447:619-628.
19. Halestrap AP, Price NT. 1999. The proton-linked monocarboxylate transporter (MCT) family: Structure, function and regulation. Biochemical Journal 343 Pt 2:281-299.
20. Helmlinger G, Sckell A, Dellian M, Forbes NS, Jain RK. 2002. Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism. Clinical Cancer Research 8:1284-1291.
21. Hockel M, Vaupel P. 2001. Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects. Journal of the National Cancer Institute 93:266-276.
22. Hsu PP, Sabatini DM. 2008. Cancer cell metabolism: Warburg and beyond. Cell 134:703-707.
23. Kirk P, Wilson MC, Heddle C, Brown MH, Barclay AN, Halestrap, AP. 2000. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO Journal 19:3896-3904.
24. Kleivi K, Teixeira MR, Eknaes M, Diep CB, Jakobsen KS, Hamelin R, Lothe RA. 2004. Genome signatures of colon carcinoma cell lines. Cancer Genetics and Cytogenetics 155: 119-131.
25. Koukourakis MI, Giatromanolaki A, Harris AL, Sivridis E. 2006. Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: A metabolic survival role for tumor-associated stroma. Cancer Research 66:632-637.
26. Kumar VB, Viji RI, Kiran MS, Sudhakaran PR. 2007. Endothelial cell response to lactate: Implication of PAR modification of VEGF. Journal of Cellular Physiology 211: 477-485.
27. Ma W, Sung HJ, Park JY, Matoba S, Hwang PM. 2007. A pivotal role for p53: Dalancing aerobic respiration and glycolysis. Journal of Bioenergetics and Biomembranes 39: 243-246.
28. Mazurek S, Boschek CB, Hugo F, Eigenbrodt E. 2005. Pyruvate kinase type M2 and its role in tumor growth and spreading. Seminars in Cancer Biology 15:300-308.
29. Mazurek S, Eigenbrodt E. 2003. The tumor metabolome. Anticancer Research 23:1149-1154.
30. Mazurek S, Zwerschke W, Jansen-Durr P, Eigenbrodt E. 2001. Metabolic cooperation between different oncogenes during cell transformation: interaction between activated ras and HPV-16 E7. Oncogene 20:6891-6898.
31. Pinheiro C, Longatto-Filho A, Scapulatempo C, Ferreira L, Martins S, Pellerin L, Rodrigues M, Alves VA, Schmitt F, Baltazar F. 2008. Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas. Virchows Archiv 452:139-146.
32. Quennet V, Yaromina A, Zips D, Rosner A, Walenta S, Baumann M, Mueller-Klieser W. 2006. Tumor lactate content predicts for response to fractionated irradiation of human squamous cell carcinomas in nude mice. Radiotherapy and Oncology 81:130-135.
33. Ribatti D, Nico B, Crivellato E, Vacca A. 2007. The structure of the vascular network of tumors. Cancer Letters 248:18-23.
34. Schmid SA, Gaumann A, Wondrak M, Eckermann C, Schulte S, Mueller-Klieser W, Wheatley DN, Kunz-Schughart LA. 2007. Lactate adversely affects the in vitro formation of endothelial cell tubular structures through the action of TGF-beta1. Experimental Cell Research 313:2531-2549.
35. Schütze C, Bergmann R, Yaromina A, Hessel F, Kotzerke J, Steinbach J, Baumann M, Beuthien-Baumann B. 2007. Effect of increase of radiation dose on local control relates to pretreatment FDG uptake in FaDu tumours in nude mice. Radiotherapy and Oncology 83:311-315.
36. Schwickert G, Walenta S, Sundfor K, Rofstad EK, Mueller- Klieser W. 1995. Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Research 55:4757-4759.
37. Sivridis E, Giatromanolaki A, Koukourakis MI. 2003. The vascular network of tumours - what is it not for? Journal of Pathology 201:173-180.
38. Sonveaux P, Vegran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, De Saedeleer CJ, Kennedy KM, Diepart C, Jordan BF, Kelley MJ, Gallez B, Wahl ML, Feron O, Dewhirst MW. 2008. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. Journal of Clinical Investigation 118:3930-3942.
39. Tatum JL, Kelloff GJ, Gillies RJ, Arbeit JM, Brown JM, Chao KS, Chapman JD, Eckelman WC, Fyles AW, Giaccia AJ, Hill RP, Koch CJ, Krishna MC, Krohn KA, Lewis JS, Mason RP, Melillo G, Padhani AR, Powis G, Rajendran JG, Reba R, Robinson SP, Semenza GL, Swartz HM, Vaupel P, Yang D, Croft B, Hoffman J, Liu G, Stone H, Sullivan D. 2006. Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy. International Journal of Radiation Biology 82:699-757.
40. Telang S, Lane AN, Nelson KK, Arumugam S, Chesney J. 2007. The oncoprotein H-RasV12 increases mitochondrial metabolism. Molecular Cancer 6:77.
41. Toulany M, Dittmann K, Kruger M, Baumann M, Rodemann HP. 2005. Radioresistance of K-Ras mutated human tumor cells is mediated through EGFR-dependent activation of PI3K-AKT pathway. Radiotherapy and Oncology 76:143-150.
42. Ullah MS, Davies AJ, Halestrap AP. 2006. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism. Journal of Biological Chemistry 281:9030-9037.
43. Vaupel P. 2004. Tumor microenvironmental physiology and its implications for radiation oncology. Seminars in Radiation Oncology 14:198-206.
44. Vaupel P, Thews O, Hoeckel M. 2001. Treatment resistance of solid tumors: Role of hypoxia and anemia. Medical Oncology 18:243-259.
45. Walenta S, Chau TV, Schroeder T, Lehr HA, Kunz-Schughart LA, Fuerst A, Mueller-Klieser W. 2003. Metabolic classification of human rectal adenocarcinomas: A novel guideline for clinical oncologists? Journal of Cancer Research and Clinical Oncology 129:321-326.
46. Walenta S, Mueller-Klieser WF. 2004. Lactate: Mirror and motor of tumor malignancy. Seminars in Radiation Oncology 14:267-274.
47. Walenta S, Salameh A, Lyng H, Evensen JF, Mitze M, Rofstad EK, Mueller-Klieser W. 1997. Correlation of high lactate levels in head and neck tumors with incidence of metastasis. American Journal of Pathology 150:409-415.
48. Walenta S, Schroeder T, Mueller-Klieser W. 2004. Lactate in solid malignant tumors: Potential basis of a metabolic classification in clinical oncology. Current Medicinal Chemistry 11:2195-2204.
49. Wilson MC, Meredith D, Halestrap AP. 2002. Fluorescence resonance energy transfer studies on the interaction between the lactate transporter MCT1 and CD147 provide information on the topology and stoichiometry of the complex in situ. Journal of Biological Chemistry 277:3666-3672.
50. Yaromina A, Krause M, Thames H, Rosner A, Krause M, Hessel F, Grenman R, Zips D, Baumann M. 2007. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation. Radiotherapy and Oncology 83:304-310.
51. Yaromina A, Quennet V, Zips D, Meyer S, Shakirin G, Walenta S, Mueller-Klieser W, Baumann M. 2009. Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts. International Journal of Radiation Biology 85:972-980.
52. Yeung SJ, Pan J, Lee MH. 2008. Roles of p53, MYC and HIF-1 in regulating glycolysis - the seventh hallmark of cancer. Cellular and Molecular Life Sciences 65:3981-3999.